# Combined Behavioral and Analgesic Trial for Fibromyalgia

> **NCT01598753** · PHASE3 · COMPLETED · sponsor: **University of Washington** · enrollment: 134 (actual)

## Conditions studied

- Fibromyalgia

## Interventions

- **DRUG:** Tramadol
- **DRUG:** Placebo
- **BEHAVIORAL:** Cognitive Behavior Therapy for FM
- **BEHAVIORAL:** Health Education

## Key facts

- **NCT ID:** NCT01598753
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2018-07-31
- **Final completion:** 2018-07-31
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01598753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01598753, "Combined Behavioral and Analgesic Trial for Fibromyalgia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01598753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*